Figures & data
Table 1. Patient selection.
Table 2. Patient baseline characteristics.
Figure 1. Propensity score weighted healthcare utilization of (A) Medicaid- and (B) Commercially insured infants in the follow-up period (excludes the index hospitalization). All p-values comparing RSV-LRTI to comparator and UB to comparator are <0.01. Abbreviations. LRTI, lower respiratory tract infection; MHP, major health problems; RSV, respiratory syncytial virus; UB, unspecified bronchiolitis; wGA, weeks gestational age.
Table 3. Propensity score weighted differences of healthcare resource utilization vs the comparator cohort in 12 months after the index date.
Figure 2. Adjusted incremental difference in mean total all-cause healthcare costs after RSV-LRTI or UB inpatient admission for (A) Medicaid- and (B) Commercially insured infants. p < 0.05 for all full year costs. p < 0.05 for all follow-up costs, except: Medicaid 29–30 wGA RSV vs no hospitalization (p = 0.111), commercial <29 wGA UB vs no hospitalization (p = 0.2368), commercial 29–30 wGA RSV vs no hospitalization (p = 0.156), commercial 29–30 wGA UB vs no hospitalization (p = 0.603), commercial 31–32 wGA UB vs no hospitalization (p = 0.089). Abbreviations. LRTI, lower respiratory tract infection; MHP, major health problems; RSV, respiratory syncytial virus; UB, unspecified bronchiolitis; USD, United States dollar; wGA, weeks gestational age.
Supplemental Material
Download MS Word (65.3 KB)Data availability
The data that support the findings of this study are available from IBM Watson Health. Restrictions apply to the availability of these data, which were used under license for this study. Derived data are available from the corresponding author with the permission of IBM Watson Health.
